Loading company…
Recordati Industria Chimica e Farmaceutica develops, manufactures and markets pharmaceuticals for rare diseases.
Founded in 1926 and based in Milan, Italy, Recordati Industria Chimica e Farmaceutica S.p.A. develops, manufactures and markets pharmaceutical products for rare diseases, and also sells pharmaceutical chemicals such as active ingredients and intermediates. The company was listed on the Italian Stock Exchange in 1984 under the ticker RECI. In December 2021, Recordati agreed to fully acquire EUSA Pharma (UK) Limited for EUR 750 million. Its brands include Carbaglu, Cosmegen and Cystadane.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Recordati Industria Chimica e Farmaceutica S.p.A.? This is my company